Abstract
The authors report a case of a congenital hypertrophy of the retinal pigment epithelium (CHRPE) associated with choroidal neovascularization (CNV) causing symptomatic vision loss. Two intravitreal injections of bevacizumab (Avastin; Genentech, South San Francisco, CA) 4 weeks apart resolved the fluid and improved the visual acuity. This case demonstrates that CHRPE can rarely be complicated by CNV, which may respond to intravitreal bevacizumab therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 276-277 |
Number of pages | 2 |
Journal | Ophthalmic Surgery Lasers and Imaging Retina |
Volume | 49 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2018 |
ASJC Scopus subject areas
- Surgery
- Ophthalmology